Investors

Company Overview

Health and Wellness

translating innovative health science into revolutionary products

We support health and wellness through the research and development of over-the-counter (OTC) products and intellectual property. Our product pipeline addresses a range of conditions, including hair loss, eczema, burns, and sexual wellness. 

We generate revenue through the sales of OTC and consumer products, contract research agreements, and licensing royalties.

View the Latest

Investor Presentation

Follow Our Latest News & Information

We’re passionate about the work we’re doing to research and develop innovative products and we want to keep you informed of our advancements. For up-to-the-minute company news delivered straight to your inbox, sign up for our email newsletter.

Scientifically Backed

PRODUCTS WITH PURPOSE

JW-100 | Topical treatment of atopic dermatitis

JW-500 | Topical treatment for female libido loss.

Minoxidil Booster | Topical treatment designed to improve Minoxidil efficacy.

Photocil | Topical treatment for psoriasis and vitiligo.

JW-300 | Topical treatment of first-degree burns and sun exposure.

JW-400 | Topical treatment of herpes labialis (cold sores).

NoStingz | Topical protection from jellyfish, sea lice, and UVA/UVB rays.

Key points about Jupiter Wellness

Publicly Traded

Jupiter Wellness is a publicly traded company listed on Nasdaq under the ticker symbol JUPW. 

Located in Jupiter, FL

Jupiter Wellness gets its namesake from our location in Jupiter, FL, where our corporate offices are headquartered. 

Backed By Science

All of the products we develop are backed by clinical research and FDA-style trials to ensure our products work well.

Sun Care

We started as a sun care company, and we still carry a line of sunscreen that protects users from the stings of jellyfish.

IP Portfolio

We have a robust and growing portfolio of granted, licensed, and pending patents to protect our proprietary products.

Email Alerts

News To Your Inbox

For up-to-the-minute company news delivered straight to your inbox, sign up for our email newsletter.